CEO Of Thoth Biosimulations Khaled Barakat Engages Global Partners at BIOCHINA 2026

Thoth Biosimulations recently participated in BIOCHINA 2026, marking a highly productive week of engagement with leading biotech and pharmaceutical organizations from around the world.

The event provided a valuable platform for targeted B2B meetings and strategic discussions focused on the future of drug discovery. In particular, there was strong interest in AI-driven approaches and advanced computational methods, highlighting the growing demand for innovative solutions in pharmaceutical development.

As part of the Canadian delegation, Thoth Biosimulations was proud to contribute to a broader showcase of Canada’s life sciences capabilities. The delegation underscored the depth of talent, research excellence, and innovation emerging from Canada’s biotechnology ecosystem.

During the conference, Thoth Biosimulations presented its work at the AI Innovation Forum. The presentation generated meaningful dialogue with industry stakeholders and led to several promising follow-up discussions, many of which are already progressing toward potential collaborations.

The company extends its appreciation to the Trade Commissioner Service, provincial partners, and event organizers for delivering a well-coordinated and impactful mission. Thoth Biosimulations also recognizes Lulu Mi for her leadership and ongoing support throughout the event.

Building on the connections established at BIOCHINA 2026, Thoth Biosimulations looks forward to advancing new partnerships and continuing to drive innovation in AI-enabled drug discovery.

CEO Dr. Khaled Barakat at BIOCHINA 2026